RadNet (RDNT) To Report Earnings Tomorrow: Here Is What To Expect
RadNet (NASDAQ:RDNT) will report earnings next after market close. The article notes last quarter’s revenue of $575.6M, up 22.1% YoY, but a miss on EPS. For the upcoming quarter, analysts expect revenue growth of 22.1% YoY. It cites an average analyst price target of $89.75 versus $71.57 and mentions peer results from Quest and Guardant Health.
How this was made
The 30-second read
Why it matters
The main tradable element is the earnings event timing and the market’s expectations for revenue growth; however, the text does not include any new company disclosure such as updated guidance, a new contract, or a regulatory development.
Market read
Traders can position for earnings volatility using the provided consensus revenue growth framing and the reminder that EPS previously missed, but there is no new guidance in the article.
What to watch
No details are provided on guidance, cash flow, or segment trends; traders should focus on EPS drivers and any commentary on utilization, reimbursement, and pricing that are not covered here.
Background
The article previews RadNet’s upcoming earnings release and summarizes last quarter’s revenue beat alongside an EPS miss, then compares peer results in the same segment.
Ticker impact
RadNet (RDNT) is scheduled to report earnings tomorrow after the close, with the article citing consensus revenue growth and prior quarter results.
Likely elevated volatility into the print, with direction dependent on EPS versus the already-cited prior miss and any updated commentary.
The newest concrete item is the scheduled earnings timing, plus consensus framing (revenue growth) and last quarter’s revenue beat and EPS miss; there is no fresh company disclosure in the text.
Market effects
Testing and diagnostics services names are referenced as having reported results, which can influence sector sentiment around earnings season.
Primarily US-focused, with NASDAQ-listed peers cited for read-through.
Limited, as the piece is centered on a single US company’s earnings timing and US-listed peer reactions.
Counterpoint
The article emphasizes revenue growth and price targets, but the prior quarter included a significant EPS miss, which can dominate the stock reaction if margins or costs disappoint again.
Key entities
- companyRadNet
NASDAQ-listed diagnostic imaging company scheduled to report earnings tomorrow after market close.
- companyQuest Diagnostics
Peer cited as having reported Q2 results with year-on-year revenue growth and a post-results stock move.
- companyGuardant Health
Peer cited as having reported Q2 revenues up year on year and a post-results stock move.
